Boule Diagnostics Announces Extraordinary General Meeting
Bitget2026/11/04 07:04- Boule Diagnostics will hold an extraordinary general meeting at its premises in Spånga on December 7, 2026.
- Shareholders will vote on a three-for-one rights issue of up to 116,499,312 shares at SEK 0.80 each.
- A proposed directed issue covers up to 78,352,790 shares at SEK 0.80 each for external investors not fully allocated rights-issue shares.
- Proposed loan amendments would enable debt-to-equity offsets and extend remaining loan maturities to June 30, 2028.
- Other proposals include revised share-count limits and a share-capital reduction of up to SEK 48.71 million without canceling shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rumor: Tesla (TSLA.US) and SpaceX (SPCX.US) plan Terafab monthly production of one million wafers, feasibility questioned
According to reports, Tesla (TSLA.US) and SpaceX (SPCX.US) plan to achieve a production capacity of 1 million semiconductor wafers per month at the proposed Terafab factory starting in 2032.

Eurozone Sentix Investor Confidence Index slips to 2.4 in November from 2.7 in October


SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
